MyRisk with RiskScore is a revolutionary tool in personalized cancer care, designed to empower both patients and doctors alike with more accurate and comprehensive information. By evaluating 48 genes associated with 11 hereditary cancers, MyRisk provides actionable insights based on sophisticated algorithms that enable individuals to develop comprehensive care plans tailored to their unique genetic profile.
The unmatched accuracy of MyRisk has been proven in peer-reviewed studies and clinical trials. In one such study published in the American Journal of Human Genetics, researchers found that MyRisk was able to detect twice as many hereditary cancer mutations compared to traditional testing methods. This superior detection rate allows for earlier diagnosis and treatment of potentially life-threatening conditions, providing a new level of confidence when making decisions about patient care.
Hereditary Cancers Tested
- Skin – Melanoma
- Endocrine – Multiple Endocrine Neoplasia